BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Tabernero, J.; Yoshino, T.; Kim, T. W.; Yaeger, R.; Desai, J.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T.; Eng, C.; Tie, J.; Fernandez, M. E. E.; Lonardi, S.; Zhang, X.; Chavira, R.; Usari, T.; Hahn, E.; Kopetz, S. |
| Abstract Title: | BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1392 |
| End Page: | S1393 |
| Language: | English |
| ACCESSION: | WOS:000866211602432 |
| DOI: | 10.1016/j.annonc.2022.08.022 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA26 -- Source: Wos |
